glp-1 approved for pcos What's been your experience with GLP-1s on your PCOS? ๐ค New research shows U.S. prescriptions drugs among women with have surged more than sevenfold since 2021โ๏ธ โThis year, 17.6% Navigating PCOS: How GLP-1 Medicines
Description
Companies should be careful with claims, however
Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8
There are still so many misconceptions about these medications among the general public
Ahead, experts answer these burning Qs
"GLP-1 drugs are a breakthrough in weight management, however, the resulting calorie deficit can come with some challenges
